Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 672 shares at $32.57 ($22K) on 2024-03-05, disclosed to the SEC on 2024-03-05.
Scheduled sale ($22k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |